Figure 1737

A number of other conditions have been reported to recur in allo-grafts. Very few patients with systemic sclerosis have received transplantation, and the incidence of acute renal failure caused by systemic sclerosis has declined with the widespread use of angiotensin-converting enzyme (ACE) inhibitors. About 20% of patients with a malignant course of scleroderma receiving a transplantation develop recurrence, which usually causes graft loss. The value of ACE inhibitors after transplantation is unknown. Two of four patients with immunotactoid glomerulopathy developed recurrent disease heralded by massive proteinuria. Transplantation in Fabry's disease rarely leads to graft-related problems; however, patients die from systemic complications of ceramide deposition.

0 0

Post a comment